<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324582/bin/CNCR-123-617-g007.jpg"/> </div> <div class="text-side"> <h1>An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi.</h1> <p>This lesion from the neck of a 71‐year‐old female was submitted as “indeterminate; favor dysplastic nevus with severe dysplasia versus evolving melanoma.” The 3 reviewing dermatopathologists all favored a benign diagnosis, but 2 of the 3 dermatopathologists noted that they could not entirely exclude early melanoma and would recommend re‐excision. The score was + 3.1. This case was counted as a false‐positive. However, note the atypical mitotic figure within a melanocyte in the papillary dermis. On the basis of the score, the submitting dermatopathologist changed his diagnosis to superficial spreading melanoma. Hematoxylin‐eosin; original magnification x20 (A), x100 (B), x200 (C), and x400 (D).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/27768230/" target="_blank">27768230</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>